Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses. The company's strategy involves researching, creating, and marketing innovative Selective Inhibitor of Nuclear Export (SINE) compounds, which operate by attaching to and deactivating the nuclear export protein XPO1. Their leading therapeutic, XPOVIO, holds approvals for several critical applications in adult patients: it is prescribed in combination with bortezomib and dexamethasone for multiple myeloma; alongside dexamethasone for those with heavily pretreated multiple myeloma; and as a standalone treatment for relapsed or refractory diffuse large B-cell lymphoma. Karyopharm has also established a licensing partnership with the Menarini Group, granting them rights to develop and market NEXPOVIO for human oncology indications across Europe (including the United Kingdom), Latin America, and other global regions. Furthermore, the company's oral SINE compounds are specifically engineered to promote the accumulation of various tumor suppressor and growth-regulating proteins within the cell nucleus. Established in 2008, Karyopharm Therapeutics Inc. maintains its principal offices in Newton, Massachusetts.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Karyopharm Therapeutics Inc.
No short interest data available.
Nasdaq bars a compliance period at 1:250
- 1:15Reverse splitFeb 26, 202515 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $146.07M | $145.24M | $146.03M | $157.07M | $209.82M | $108.08M | $40.89M | $30.34M | $1.6M | $154K | $250K | $229K | $387K | $634K | $152K |
| YoY Growth | 0.6% | -0.5% | -7.0% | -25.1% | 94.1% | 164.3% | 34.8% | 1790.1% | 942.2% | -38.4% | 9.2% | -40.8% | -39.0% | 317.1% | - |
| Cost of Revenue | $5.95M | $6.01M | $4.94M | $5.21M | $3.4M | $2.71M | $2.41M | $161.37M | $107.27M | $86.94M | $97.74M | $60.13M | $28.45M | $14.1M | $0 |
| Gross Profit | $140.12M | $139.23M | $141.09M | $151.86M | $206.42M | $105.38M | $38.49M | -$131.04M | -$105.67M | -$86.78M | -$97.49M | -$59.9M | -$28.07M | -$13.46M | $152K |
| Gross Margin | 95.9% | 95.9% | 96.6% | 96.7% | 98.4% | 97.5% | 94.1% | -431.9% | -6583.7% | -56353.2% | -38997.6% | -26156.3% | -7251.9% | -2123.2% | 100.0% |
| Research and Development | $125.62M | $143.23M | $138.75M | $148.66M | $160.84M | $150.81M | $122.34M | $161.37M | $107.27M | $86.94M | $97.74M | $60.13M | $28.45M | $14.1M | $8.62M |
| Selling, General, and Administrative | $105.21M | $115.44M | $131.88M | $145.4M | $143.85M | $126.42M | $105.42M | $48.85M | $24.87M | $23.95M | $21.58M | $15.95M | $5.88M | $2.43M | $1.84M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$33K | -$81K | $10K | -$2K | -$27K | $0 | $0 | $0 |
| Total Operating Expenses | $230.82M | $258.67M | $270.63M | $294.06M | $304.69M | $277.23M | $227.76M | $210.22M | $132.14M | $110.89M | $119.33M | $76.08M | $34.34M | $16.52M | $10.46M |
| Operating Income (EBIT) | -$90.71M | -$119.44M | -$129.54M | -$142.2M | -$98.27M | -$171.85M | -$189.28M | -$179.88M | -$130.54M | -$110.73M | -$119.08M | -$75.85M | -$33.95M | -$15.89M | -$10.31M |
| Operating Margin | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% | -462.9% | -593.0% | -8133.2% | -71903.9% | -47630.4% | -33120.5% | -8772.6% | -2506.3% | -6783.6% |
| Interest Expense | $45.85M | $37.42M | $23.82M | $25M | $26.05M | $27.14M | $15.65M | $2.49M | $0 | $0 | $0 | $1K | $0 | $0 | $0 |
| Interest Income | $2.77M | $7.4M | $10.94M | $2.36M | $582K | $2.82M | $5.42M | $4.03M | $1.7M | $1.28M | $897K | $97K | $3K | $2K | $0 |
| Other Income (Expense) | -$105.29M | $43.08M | -$13.24M | -$22.72M | -$25.55M | -$24.11M | -$10.28M | $1.5M | $1.62M | $1.29M | $895K | $69K | $3K | $2K | $0 |
| Income Before Tax (EBT) | -$196M | -$76.36M | -$142.78M | -$164.92M | -$123.82M | -$195.96M | -$199.55M | -$178.38M | -$128.92M | -$109.44M | -$118.18M | -$75.78M | -$33.95M | -$15.89M | -$10.31M |
| Income Tax Expense | $43K | $57K | $323K | $369K | $268K | $309K | $40K | $26K | $63K | $139K | -$895K | -$69K | -$3K | -$2K | $0 |
| Net Income | -$196.04M | -$76.42M | -$143.1M | -$165.29M | -$124.09M | -$196.27M | -$199.59M | -$178.41M | -$128.98M | -$109.58M | -$118.18M | -$75.78M | -$33.95M | -$15.89M | -$10.31M |
| Net Income Margin | -134.2% | -52.6% | -98.0% | -105.2% | -59.1% | -181.6% | -488.1% | -588.1% | -8036.4% | -71153.9% | -47272.4% | -33090.4% | -8771.8% | -2506.0% | -6783.6% |
| Supplementary Data | |||||||||||||||
| EPS | -17.93 | -9.41 | -18.79 | -30.28 | -24.75 | -40.87 | -48.32 | -47.11 | -42.15 | -43.80 | -49.80 | -36.45 | -83.85 | -8.01 | -5.20 |
| Diluted EPS | -17.93 | -9.41 | -18.79 | -30.28 | -24.75 | -40.87 | -48.32 | -47.11 | -42.15 | -43.80 | -49.80 | -36.45 | -83.85 | -8.01 | -5.20 |
| Weighted Average OS | 10.94M | 8.12M | 7.61M | 5.46M | 5.01M | 4.80M | 4.13M | 3.79M | 3.06M | 2.50M | 2.37M | 2.08M | 404,511 | 132,220 | 132,220 |
| EBITDA | -$149.85M | -$38.6M | -$118.42M | -$139.31M | -$96.98M | -$167.85M | -$182.93M | -$175.15M | -$128.21M | -$108.72M | -$118.44M | -$75.45M | -$33.8M | -$15.77M | -$10.23M |
| EBITDA Margin | -102.6% | -26.6% | -81.1% | -88.7% | -46.2% | -155.3% | -447.3% | -577.4% | -7988.0% | -70598.1% | -47376.8% | -32949.3% | -8734.6% | -2486.8% | -6728.9% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $60.54M | $62.48M | $52.23M | $135.19M | $190.46M | $85.92M | $128.86M | $118.02M | $69M | $49.66M | $58.36M | $150.61M | $155.97M | $391K | $6.51M |
| Short-Term Investments | $3.2M | $46.24M | $139.21M | $142.78M | $38.16M | $163.32M | $133.1M | $210.18M | $77.47M | $79.89M | $117.28M | $55.12M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $63.74M | $108.71M | $191.44M | $277.97M | $228.62M | $249.24M | $261.96M | $328.2M | $146.47M | $129.55M | $175.63M | $205.72M | $155.97M | $391K | $6.51M |
| Accounts Receivable | $26.18M | $30.77M | $26.96M | $47.09M | $22.5M | $12.88M | $7.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $4.04M | $4.74M | $3.04M | $4.22M | $4.11M | $2.64M | $346K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $9.19M | $12.28M | $12.47M | $20.89M | $6.35M | $2.48M | $1.12M | $0 | $200K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $103.15M | $156.49M | $233.92M | $350.16M | $275.61M | $276.53M | $278.57M | $334.61M | $148.42M | $131.64M | $177.6M | $207.75M | $157.96M | $954K | $6.87M |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $4.65M | $6.28M | $4.88M | $7.38M | $9.56M | $11.58M | $13.66M | $3.86M | $2.19M | $2.84M | $3.48M | $2.75M | $240K | $327K | $328K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $351K | $0 | $0 | $0 | $0 | $24.21M | $2.02M | $2M | $29.4M | $45.43M | $33.88M | $8.66M | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $267K | $1.64M | $1.64M | $633K | $20.14M | $722K | $714K | $716K | $290K | $479K | $482K | $1.17M | $30K | $30K | $30K |
| Total Long-Term Assets | $5.27M | $7.93M | $6.52M | $8.01M | $29.7M | $36.52M | $16.39M | $6.58M | $31.87M | $48.75M | $37.84M | $12.59M | $270K | $357K | $358K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $108.42M | $164.42M | $240.44M | $358.17M | $305.31M | $313.05M | $294.96M | $341.19M | $180.29M | $180.38M | $215.44M | $220.34M | $158.23M | $1.31M | $7.22M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $4M | $5.11M | $3.12M | $2.77M | $1.6M | $4.45M | $985K | $4.33M | $5.67M | $4.75M | $3.81M | $6.29M | $1.74M | $1.08M | $1.14M |
| Short-Term Debt | $21.01M | $24.43M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $297K | $2.34M | $9.36M | $21.92M | $0 | $0 | $0 | $79K | $66K | $200K |
| Other Current Liabilities | $5.96M | $15.56M | $18.16M | $21.47M | $20.36M | $609K | $500K | $717K | $436K | $363K | $301K | $188K | $305K | $24K | $16K |
| Total Current Liabilities | $92.06M | $92.26M | $69.48M | $65.91M | $73.72M | $60.2M | $46.35M | $46.9M | $49.47M | $16.48M | $15.13M | $12.3M | $3.29M | $1.93M | $2.12M |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $205.88M | $162.95M | $170.92M | $170.1M | $169.29M | $117.93M | $109.86M | $102.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $72.34M | $0 | $0 | $0 | $0 | $0 | $2.19M | $4.53M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $25.32M | $88.51M | $133.46M | $132.72M | $133M | $73.09M | $73.59M | $3.92M | $1.36M | $1.67M | $1.95M | $1.24M | $0 | $27.26M | $17.76M |
| Total Long-Term Liabilities | $309.28M | $258.17M | $307.17M | $308.92M | $311.26M | $202.3M | $198.84M | $111.12M | $1.36M | $1.67M | $1.95M | $1.24M | $0 | $27.26M | $17.76M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $401.34M | $350.44M | $376.64M | $374.83M | $384.98M | $262.5M | $245.19M | $158.02M | $50.83M | $18.14M | $17.08M | $13.54M | $3.29M | $29.19M | $19.88M |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $14K | $13K | $12K | $12K | $8K | $7K | $7K | $6K | $5K | $4K | $4K | $3K | $3K | $0 | $0 |
| Retained Earnings | -$1.76B | -$1.56B | -$1.49B | -$1.34B | -$1.18B | -$1.07B | -$873.34M | -$673.75M | -$495.34M | -$366.1M | -$256.53M | -$138.35M | -$62.57M | -$28.62M | -$12.73M |
| Comprehensive Income & Other | $71K | -$356K | -$161K | -$638K | $191K | $518K | -$37K | -$244K | -$217K | -$274K | -$282K | -$29K | $0 | $0 | $0 |
| Other Stockholders' Equity | $1.47B | $1.38B | $1.35B | $1.33B | $1.1B | $1.12B | $923.11M | $856.91M | $624.8M | $528.34M | $454.89M | $345.14M | $217.5M | $745K | $83K |
| Total Equity | -$292.93M | -$186.02M | -$136.21M | -$16.66M | -$79.67M | $50.55M | $49.77M | $183.17M | $129.46M | $162.24M | $198.37M | $206.79M | $154.93M | -$27.88M | -$12.65M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $108.42M | $164.42M | $240.44M | $358.17M | $305.31M | $313.05M | $294.96M | $341.19M | $180.29M | $180.38M | $215.44M | $220.34M | $158.23M | $1.31M | $7.22M |
| Supplementary Data | |||||||||||||||
| Total Debt | $233.61M | $194.52M | $177.02M | $179.07M | $180.58M | $131.13M | $124.7M | $102.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | $173.07M | $132.05M | $124.78M | $43.89M | -$9.88M | $45.21M | -$4.15M | -$15.36M | -$69M | -$49.66M | -$58.36M | -$150.61M | -$155.97M | -$391K | -$6.51M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | -$196.04M | -$76.42M | -$143.1M | -$165.29M | -$124.09M | -$196.27M | -$199.59M | -$178.41M | -$128.98M | -$109.58M | -$118.18M | -$75.78M | -$33.95M | -$15.89M | -$10.31M |
| Depreciation & Amortization | $296K | $340K | $530K | $621K | $789K | $972K | $974K | $735K | $713K | $717K | $634K | $323K | $144K | $122K | $83K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $1.45M | $904K | -$1.38M | $29K | $0 | $0 | $1.78M | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $14.05M | $18.43M | $21.71M | $35.4M | $29.78M | $24.41M | $15.29M | $17.27M | $20.41M | $22.28M | $17.06M | $14.24M | $3.79M | $653K | $24K |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | $4.59M | -$3.8M | $20.12M | -$5.08M | -$9.62M | -$5.02M | -$7.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $701K | -$1.7M | $1.18M | -$118K | -$1.46M | -$2.63M | -$346K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$1.1M | $1.98M | $350K | $1.17M | -$2.85M | $3.46M | -$3.3M | -$1.38M | $909K | $945K | -$2.43M | $4.5M | $664K | -$66K | $1.13M |
| Other Working Capital | $24.09M | $3.21M | $9.76M | -$15.96M | -$9.26M | $5.54M | -$1.8M | $1.21M | $32.05M | $42K | $6.42M | $5.22M | -$1.02M | -$330K | $524K |
| Total Working Capital Change | $28.27M | -$302K | $31.41M | -$19.99M | -$23.19M | $1.36M | -$13.31M | -$169K | $32.96M | $987K | $4M | $9.71M | -$360K | -$396K | $1.66M |
| Other Non-Cash Items | $78.05M | -$69.53M | -$3.28M | -$294K | $8.13M | $8.4M | $7.19M | $1.42M | $1.19M | $1.2M | $685K | $52K | $88K | $257K | $0 |
| Net Cash from Operating | -$75.37M | -$127.49M | -$92.72M | -$149.55M | -$107.12M | -$160.23M | -$190.82M | -$159.12M | -$73.72M | -$84.39M | -$94.03M | -$51.45M | -$30.29M | -$15.51M | -$8.55M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | $0 | -$142K | $0 | -$118K | -$5.71M | -$145K | -$206K | -$2.36M | -$62K | -$70K | -$1.42M | -$2.83M | -$57K | -$121K | -$376K |
| Acquisitions | $0 | $0 | $0 | $104.26M | $5.5M | $53.54M | -$78.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$58.82M | -$159.15M | -$226.02M | -$45.23M | -$274.58M | -$178.49M | -$242.81M | -$98.37M | -$134.7M | -$305.19M | -$63.8M | $0 | $0 | $0 |
| Sales of Investments | $43.38M | $154.44M | $167.09M | $121.88M | $192.78M | $221.04M | $257.14M | $137.51M | $115.54M | $159.37M | $215.87M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$104.26M | -$5.5M | -$53.54M | $78.66M | -$105.3M | $17.17M | $24.66M | -$82K | -$400K | $0 | $0 | $0 |
| Net Cash from Investing | $43.38M | $95.47M | $7.94M | -$104.26M | $141.84M | -$53.69M | $78.45M | -$107.66M | $17.11M | $24.59M | -$90.82M | -$67.03M | -$57K | -$121K | -$376K |
| Financing Activities | |||||||||||||||
| Debt Repaid | -$20.54M | -$83.3M | - | - | -$60M | - | - | -$166.88M | - | - | - | - | - | - | - |
| Common Stock Issuance | $9.51M | $1.45M | $1.12M | $189.76M | $9.9M | $161.78M | $46.19M | $145.71M | $74.89M | $50.57M | $92.08M | $112.84M | $113.16M | $9K | $12K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$43.11M | $0 | $3.98M | $3.75M | $10.31M | $78.11M | $3.52M | $858K | $591K | $616K | $284K | $341K | $0 | $0 |
| Net Cash from Financing | $30.05M | $41.65M | $1.12M | $193.74M | $73.65M | $172.08M | $124.31M | $316.11M | $75.74M | $51.16M | $92.7M | $113.12M | $185.93M | $9.51M | $11.99M |
| Forex Effect | $20K | -$11K | -$34K | -$488K | -$48K | $268K | $19K | -$78K | $200K | -$63K | -$99K | -$8K | $0 | $0 | $0 |
| Net Change in Cash | -$1.92M | $9.62M | -$83.69M | -$60.56M | $108.32M | -$41.57M | $11.95M | $49.25M | $19.33M | -$8.7M | -$92.25M | -$5.37M | $155.58M | -$6.12M | $3.07M |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$75.37M | -$127.49M | -$92.72M | -$149.55M | -$107.12M | -$160.23M | -$190.82M | -$159.12M | -$73.72M | -$84.39M | -$94.03M | -$51.45M | -$30.29M | -$15.51M | -$8.55M |
| Capital Expenditure | $0 | -$142K | $0 | -$118K | -$5.71M | -$145K | -$206K | -$2.36M | -$62K | -$70K | -$1.42M | -$2.83M | -$57K | -$121K | -$376K |
| Free Cash Flow | -$75.37M | -$127.63M | -$92.72M | -$149.67M | -$112.83M | -$160.38M | -$191.03M | -$161.48M | -$73.78M | -$84.46M | -$95.44M | -$54.28M | -$30.35M | -$15.63M | -$8.93M |
| Cash at Beginning | $62.81M | $53.19M | $136.88M | $197.44M | $89.12M | $130.69M | $118.74M | $69.49M | $49.66M | $58.36M | $150.61M | $155.97M | $391K | $6.51M | $3.44M |
| Cash at End | $60.89M | $62.81M | $53.19M | $136.88M | $197.44M | $89.12M | $130.69M | $118.74M | $69M | $49.66M | $58.36M | $150.61M | $155.97M | $391K | $6.51M |